FY2026 · period end Jan '26 · from the 10-K filed Mar 26, 2026
| Metric | FY26Jan '26 | FY25Feb '25 | FY24Feb '24 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Revenue | $12.39B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001104659-26-071896 | Jun 9, 2026 | Jun 9, 2026 | Jun 9, 2026 21:01 UTC | EDGAR |
| 8-K | 0001104659-26-069464 | Jun 2, 2026 | Jun 2, 2026 | Jun 2, 2026 20:06 UTC | EDGAR |
| 10-Q | 0001104659-26-069491 | May 2, 2026 | Jun 2, 2026 | Jun 2, 2026 20:19 UTC | EDGAR |
| 10-K | 0001104659-26-035243 | Jan 31, 2026 | Mar 26, 2026 | Mar 26, 2026 20:33 UTC | EDGAR |
| 8-K | 0001104659-26-027061 | Mar 12, 2026 | Mar 12, 2026 | Mar 12, 2026 20:07 UTC | EDGAR |
| 8-K | 0001104659-25-122603 | Dec 15, 2025 | Dec 18, 2025 | Dec 18, 2025 22:08 UTC | EDGAR |
| 8-K | 0001104659-25-118457 | Dec 4, 2025 | Dec 4, 2025 | Dec 4, 2025 21:07 UTC | EDGAR |
| 10-Q | 0001104659-25-118458 | Nov 1, 2025 | Dec 4, 2025 | Dec 4, 2025 21:09 UTC | EDGAR |
Direct links to SEC EDGAR. ULTA has additional filings available on the SEC site.
6 numbers Ulta Beauty, Inc. later changed — same XBRL tag, both filings linked.
Other Accrued Liabilities, Current·As of Feb 3, 2018
Major restatementwas$32.6M
Revised up in a 10-K.
Increase (Decrease) in Accrued Liabilities·FY 2019
Major restatementwas$79.9M
Revised down in a 10-K.
Increase (Decrease) in Accrued Liabilities·Q2 2018
Major restatementwas-$13.1M
Revised up in a 10-Q.
Accrued Liabilities, Current·As of May 5, 2018
Major restatementwas$320.4M
Revised down in a 10-Q.
Accrued Liabilities, Current·As of Aug 4, 2018
Major restatementwas$348.9M
Revised down in a 10-Q.
Contract with Customer, Liability, Revenue Recognized·Q3 2018
Major restatementwas$85.3M
Revised down in a 10-Q.
ULTA is not the only one.
See every restatement we've found across the market — or get an alert the next time ULTA revises a number.
Restatements are detected by comparing every vintage of a fact across all of Ulta Beauty, Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ULTA's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Ulta Beauty, Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ULTA yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ULTA and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $11.21B |
| $10.21B |
| $8.63B |
| Gross Profit | $4.85B | $4.39B | $4.38B | $4.04B | $3.37B |
|---|
| Operating Income | $1.53B | $1.56B | $1.68B | $1.64B | $1.30B |
|---|
| Net Income | $1.15B | $1.20B | $1.29B | $1.24B | $0.99B |
|---|
| EPS (Diluted) | $25.64 | $25.34 | $26.03 | $24.01 | $17.98 |
|---|
| Metric | FY26Jan '26 | FY25Feb '25 | FY24Feb '24 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Total Assets | $7.00B | $6.00B | $5.71B | $5.37B | $4.76B |
| Total Liabilities | $4.20B | $3.51B | $3.43B | $3.41B | $3.23B |
| Stockholders' Equity | $2.80B | $2.49B | $2.28B | $1.96B | $1.54B |
| Cash & Equivalents | $0.42B | $0.70B | $0.77B | $0.74B | $0.43B |
| Total Debt | — | — | — | — | — |
| Metric | FY26Jan '26 | FY25Feb '25 | FY24Feb '24 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.50B | $1.34B | $1.48B | $1.48B | $1.06B |
| Capital Expenditures | $0.43B | $0.37B | $0.44B | $0.31B | $0.17B |
| Free Cash Flow | $1.07B | $0.96B | $1.04B | $1.17B | $0.89B |
| Metric | FY26Jan '26 | FY25Feb '25 | FY24Feb '24 | FY23Jan '23 | FY22Jan '22 |
|---|---|---|---|---|---|
| Gross Margin | 39.1% | 38.8% | 39.1% | 39.6% | 39.0% |
| Operating Margin | 0.1% | 0.1% | 15.0% | 0.2% | 0.2% |
| Net Margin | 0.1% | 0.1% | 11.5% | 0.1% | 0.1% |
| Return on Equity | 50.4% | 56.6% | 56.6% | 71.1% | 55.8% |
| Return on Assets | 20.5% | 22.6% | 22.6% | 24.5% | 20.0% |
| Debt / Equity | 0.08× | 0.09× | — | — | — |
